View the PDF

Includes: Beyond PSMA in Prostate Cancer: STEAP1, DLL3, and CD46, Genomic classifier score linked with focal therapy outcomes in prostate cancer, Predicting prostate cancer recurrence through power of AI, Model Predicts Prostate Cancer Mortality at the Point of PSA Screening, Spotlighting the Top 10 FDA Oncology Approvals in 2025, CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction, and more.